These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8093593)

  • 1. Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis.
    Sautter F; McDermott B; Garver D
    Biol Psychiatry; 1993 Jan; 33(1):15-21. PubMed ID: 8093593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family study of lithium-responsive psychosis.
    Sautter FJ; McDermott BE; Garver DL
    J Affect Disord; 1990 Sep; 20(1):63-9. PubMed ID: 2147191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial differences in lithium responsive versus lithium nonresponsive psychoses.
    Sautter F; Garver D
    J Psychiatr Res; 1985; 19(1):1-8. PubMed ID: 3989734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of gender differences in neuroleptic response in patients with schizophrenia.
    Pinals DA; Malhotra AK; Missar CD; Pickar D; Breier A
    Schizophr Res; 1996 Dec; 22(3):215-22. PubMed ID: 9000318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to lithium in patients with psychoses.
    Schexnayder LW; Hirschowitz J; Sautter FJ; Garver DL
    Am J Psychiatry; 1995 Oct; 152(10):1511-3. PubMed ID: 7573592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients.
    Joober R; Rouleau GA; Lal S; Bloom D; Lalonde P; Labelle A; Benkelfat C
    Schizophr Res; 2005 Sep; 77(1):35-41. PubMed ID: 16005383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early interventions in a US military FIRST episode psychosis program.
    Hann MC; Caporaso E; Loeffler G; Cuellar A; Herrington L; Marrone L; Yoon J
    Early Interv Psychiatry; 2018 Dec; 12(6):1243-1249. PubMed ID: 29971958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of antipsychotic effects of neuroleptic drugs.
    Keck PE; Cohen BM; Baldessarini RJ; McElroy SL
    Am J Psychiatry; 1989 Oct; 146(10):1289-92. PubMed ID: 2571305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness.
    Miller R
    Psychopharmacology (Berl); 1987; 92(4):405-15. PubMed ID: 2888150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study].
    Romain JL; Dermain P; Greslé P; Grignon S; Moisan P; Nore D; Pech G; Benyaya J; Perret I
    Encephale; 1996; 22(4):280-6. PubMed ID: 9035983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotogenic drug use and neuroleptic response.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Schizophr Bull; 1990; 16(1):81-5. PubMed ID: 1970670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justifying neuroleptic drug treatment.
    Overall JE; Garza-Trevino E; Rhoades HM; Volkow ND; Cecil S
    Hosp Community Psychiatry; 1989 Jul; 40(7):749-51. PubMed ID: 2570741
    [No Abstract]   [Full Text] [Related]  

  • 16. Acutely psychotic patients: a treatment approach.
    Wagemaker H; Lippmann S; Cade JR
    South Med J; 1985 Jul; 78(7):833-7. PubMed ID: 2861662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of schizoaffective disorders.
    Goodnick PJ; Meltzer HY
    Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective 1-5 year outcome study in first-admitted and readmitted schizophrenic patients; relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment.
    Wieselgren IM; Lindstrom LH
    Acta Psychiatr Scand; 1996 Jan; 93(1):9-19. PubMed ID: 8919324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
    Simhandl C; Meszaros K
    J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.